[{"uuid": "9a4412c4-1621-4ac8-bb0e-a9a762b37307", "publishTime": "2021-09-21T17:47:45.000Z", "title": "Amgen blocks Sandoz, Zydus generics of psoriasis drug Otezla until 2028", "description": "Amgen has won a ruling in New Jersey federal court that blocks Sandoz Inc and Zydus Pharmaceuticals' proposed generics of its blockbuster psoriasis drug Otezla until 2028, the company said.", "assetTags": ["Amgen", "AMGN NASDAQ", "AMGN US"], "searchTags": ["AMGN"], "category": "major_publication", "url": "https://www.reuters.com/legal/transactional/amgen-blocks-sandoz-zydus-generics-psoriasis-drug-otezla-until-2028-2021-09-21/?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://www.reuters.com/resizer/z_u7n7vCAn9iATAw1tY6m6-UZPk=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/OIEX2LJBC5LM3I3NCROFR7XB5I.jpg"], "lang": "en", "cityfalconScore": 54, "additionalData": {}, "source": {"name": "reuters.com", "brandName": "Reuters", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/large.png"}}, "duplicatesCount": 1, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/amgen-amgn"}, {"uuid": "40ecd228-f2ae-4115-b76b-90722e27e170", "publishTime": "2021-10-08T12:08:48.000Z", "title": "AstraZeneca's experimental asthma gets an orphan drug designation for another disease", "description": "U.S.-listed shares of AstraZeneca gained 0.3% in premarket trading on Friday after the company said an experimental asthma drug it is developing with Amgen has been given an orphan drug designation as a treatment for eosinophilic esophagitis, a rare inflammatory disease. The Food and Drug Administration is expected to decide whether to approve the investigational therapy, tezepelumab, for asthma in the first three months of 2022. AstraZeneca's stock is up 20.7% for the year, while the S&P 500 has gained 16.1%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.", "assetTags": ["Amgen", "AMGN NASDAQ", "AMGN US"], "searchTags": ["AMGN"], "category": "major_publication", "url": "https://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/yn8JHVUqeSg/story.aspx?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": null, "lang": "en", "cityfalconScore": 47, "additionalData": {}, "source": {"name": "marketwatch.com", "brandName": "MarketWatch", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/large.png"}}, "duplicatesCount": 0, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/amgen-amgn"}]